Eisai’s 10 billion Japanese yen ($69 million) bet on injectable drug delivery is complete. The Japanese drug developer plowed the money into the construction of an injectable formulation research building, positioning it to continue its expansion beyond oral drug delivery.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,